Efficacy and safety of Idecabtagene Vicleucel (ide-cel, bb2121) in elderly patients (Pts) with relapsed and refractory multiple myeloma (RRMM): KarMMa subgroup analysis

Autores: Einsele, H.; Berdeja, J.; Raje, N. S.; Siegel, D. S.; Lin, Y.; Anderson, L. D.; Rodríguez Otero, Paula; Manier, S.; Cavo, M.; Truppel-Hartmann, A.; Rowe, E.; Sanford, J.; Wang, J.; Campbell, T. B.; Jagannath, S.